Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-001574-24Phase 4Completed
Phase 4, single-arm trial of somatropin in growth hormone deficiency (GHD) and coronary arteriosclerosis, sponsored by Radboud University Medical Center. Primary endpoint: Presence of atherosclerotic disease in the coronary system. Started Jun 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-001574-24.